Netflix stock battered as investors await a flood of new competitors
With a huge lead in subscribers and a packed programming schedule, Netflix is in no immediate danger.
All Posts in "Market Watch"
U.S. ran deficit just under $1 trillion in 2019, CBO estimates
Final figure to be released later this month
Stocks close lower as optimism over upcoming U.S.-China trade meeting wanes
High-level talks are set to begin Thursday
GE freezing pensions for 20,000 employees
Stock turns lower; GE to record charge as it offers lump-sum payment option to 100,000 former employees
German manufacturing orders weaker than expected
German manufacturing orders fell August, data from the Federal Statistical Office showed Monday, boosting the likelihood of economic contraction in the third quarter in Europe’s largest economy.
Asian markets mixed ahead of renewed U.S.-China trade talks
Nikkei loses early gains, while Australian stocks rise
European stocks turn higher as Wall Street open approaches
European stocks on Monday turned higher in afternoon trade, led by pharmaceutical and food producers.
Purdue opioid deal blasted as records show $13 billion to Sacklers
Documents say members of the Sackler family made $12 billion to $13 billion from Purdue, a higher amount than court records had previously given
What’s driving the rare simultaneous rise in gold and the dollar
How to trade this trend
The GM strike is really about the switch to electric cars
Auto-assembly workers are in a difficult position — fewer of them will be needed
Drug based on anti-nausea agent reduces Alzheimer’s-advancing astrocytes in mice, biotech says
FDA elevates recall as Zimmer Biomet phases out hip replacement implant
Alkeus’ oral eye disease asset fails to significantly reduce lesion growth in phase 3
Rakovina deepens AI focus with cancer collab to select DNA-damage response kinase targets
FDA clears Senseonics’ 365-day Eversense CGM implant
Merck, Daiichi rack up phase 3 ADC lung cancer win but report 2 deaths, immature OS data
Ascendis’ dwarfism drug accelerates growth in phase 3, teeing up challenge to BioMarin
Trispecific antibody from Ichnos Glenmark Innovation beats J&J’s Tecvayli at treating multiple myeloma in mice
American Consumers Feeling Less Confident in December, Conference Board Says
Biden Will Decide on US Steel Acquisition After Influential Panel Fails to Reach Consensus